Cargando…

Indirect costs of rheumatoid arthritis

It is estimated that in Poland about 400,000 persons in general suffer from inflammatory joint diseases, including rheumatoid arthritis (RA). Epidemiological surveys documenting the frequency and disturbance of musculoskeletal disorders in the Polish population are few in number. Most of the estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Raciborski, Filip, Kłak, Anna, Kwiatkowska, Brygida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847321/
https://www.ncbi.nlm.nih.gov/pubmed/27407258
http://dx.doi.org/10.5114/reum.2015.55830
_version_ 1782429192622702592
author Raciborski, Filip
Kłak, Anna
Kwiatkowska, Brygida
author_facet Raciborski, Filip
Kłak, Anna
Kwiatkowska, Brygida
author_sort Raciborski, Filip
collection PubMed
description It is estimated that in Poland about 400,000 persons in general suffer from inflammatory joint diseases, including rheumatoid arthritis (RA). Epidemiological surveys documenting the frequency and disturbance of musculoskeletal disorders in the Polish population are few in number. Most of the estimations are based on epidemiological data from other countries (prevalence of 0.5–1%). According to the data of the National Health Fund in Poland 135,000–157,000 persons in total are treated because of rheumatoid arthritis per year [ICD10 (International Statistical Classification of Diseases and Related Health Problems): M05, M06]. In the case of this group of diseases indirect costs significantly outweigh the direct costs. Indirect costs increase together with activity level of the disease. The cost analysis of productivity loss of RA patients indicates that sickness absenteeism and informal care are the most burdensome. At the national level it amounts in total from 1.2 billion to 2.8 billion PLN per year, depending on the method of analysis. These costs could be significantly reduced through early diagnosis and introduction of effective treatment.
format Online
Article
Text
id pubmed-4847321
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
record_format MEDLINE/PubMed
spelling pubmed-48473212016-07-12 Indirect costs of rheumatoid arthritis Raciborski, Filip Kłak, Anna Kwiatkowska, Brygida Reumatologia Review Paper It is estimated that in Poland about 400,000 persons in general suffer from inflammatory joint diseases, including rheumatoid arthritis (RA). Epidemiological surveys documenting the frequency and disturbance of musculoskeletal disorders in the Polish population are few in number. Most of the estimations are based on epidemiological data from other countries (prevalence of 0.5–1%). According to the data of the National Health Fund in Poland 135,000–157,000 persons in total are treated because of rheumatoid arthritis per year [ICD10 (International Statistical Classification of Diseases and Related Health Problems): M05, M06]. In the case of this group of diseases indirect costs significantly outweigh the direct costs. Indirect costs increase together with activity level of the disease. The cost analysis of productivity loss of RA patients indicates that sickness absenteeism and informal care are the most burdensome. At the national level it amounts in total from 1.2 billion to 2.8 billion PLN per year, depending on the method of analysis. These costs could be significantly reduced through early diagnosis and introduction of effective treatment. Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015-12-08 2015 /pmc/articles/PMC4847321/ /pubmed/27407258 http://dx.doi.org/10.5114/reum.2015.55830 Text en Copyright © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015 http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Review Paper
Raciborski, Filip
Kłak, Anna
Kwiatkowska, Brygida
Indirect costs of rheumatoid arthritis
title Indirect costs of rheumatoid arthritis
title_full Indirect costs of rheumatoid arthritis
title_fullStr Indirect costs of rheumatoid arthritis
title_full_unstemmed Indirect costs of rheumatoid arthritis
title_short Indirect costs of rheumatoid arthritis
title_sort indirect costs of rheumatoid arthritis
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847321/
https://www.ncbi.nlm.nih.gov/pubmed/27407258
http://dx.doi.org/10.5114/reum.2015.55830
work_keys_str_mv AT raciborskifilip indirectcostsofrheumatoidarthritis
AT kłakanna indirectcostsofrheumatoidarthritis
AT kwiatkowskabrygida indirectcostsofrheumatoidarthritis